You are here: Industry Insights > Purchase

News List

I-Mab Announces Execution of Senior Management Team Share Purchase Plan prnasia
January 17, 2022
I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the senior management team of the Company...
China’s drug bulk-buy programme has been expanded europeanpharmaceuticalreview
September 04, 2019
China has expanded a pilot drug bulk-buying programme to almost the entire country which is adding pressure on pharma companies.
Teva Completes Facilities Purchase in Pennsylvania americanpharmaceuticalreview
July 16, 2019
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa., which, together with three other buildings Teva owns in ...
Lundbeck to purchase Abide Therapeutics in $400m deal pharmaceutical-technology
May 08, 2019
Danish pharmaceutical company Lundbeck has signed a $400m definitive agreement to acquire US-based Abide Therapeutics.
Big pharma loses out in China's latest procurement program fiercepharma
December 10, 2018
In a Battle of Waterloo-style defeat, off-patent drugs from big pharma firms lost major markets in China as the government adopted a novel procurement scheme to slash generic drug costs.
Roche inks deal to purchase Jecure Therapeutics firstwordpharma
November 28, 2018
Roche's Genentech unit has entered into a definitive agreement to acquire Jecure Therapeutics, obtaining full rights to the latter’s entire preclinical portfolio of NLRP3 inhibitors, Jecure announced Tuesday. Financial terms of the deal were not divulged.
Cambrex adds Avista Pharma to the fold in $250M deal fiercepharma
November 26, 2018
CDMO Cambrex likes its deals big or small. In September it closed the $425 million deal acquisition of Halo Pharma. This week it is buying a four-facility competitor in a $250 million deal.